Table 11. The genes targeted by the 30 potential drugs.
NPC1 (20) U | IL1B (14) U | PPP3CA (10) U | HSPA1A (4) U | PTBP1 (3) U |
CYP51A1 (2) U | RNASEH1 (1) U | CDK19 (1) U | AKT3 (1) U | INSR (1) U |
TP53 (23) D | ADRB2 (23) D | RGS4 (22) D | SMPD1 (17) D | POLI (17) D |
BAZ2B (15) D | MMP14 (15) D | BCL2L1 (15) D | NR2F2 (14) D | SUMO1 (14) D |
VIPR1 (10) D | EGFR (10) D | ID4 (9) D | RXRA (7) D | PLEC (5) D |
NLRP1 (5) D | STAT1 (4) D | WEE1 (4) D | STK3 (3) D | SRPK1 (3) D |
SGK1 (3) D | MKNK2 (3) D | DUSP1 (2) D | PLAU (1) D | CDC42BPA (1) D |
CDK2 (1) D | KDR (1) D | SIK1 (1) D |
Note:
The parentheses represent the number of associated cMap drugs, U and D represent up and down-regulated respectively.